RpoB
RpoB is a gene that encodes the beta subunit of RNA polymerase in bacteria. This gene is essential for bacterial viability and is the target of the antibiotic rifampicin. Mutations in this gene can lead to rifampicin resistance in bacteria.
Function[edit]
The RpoB gene encodes the beta subunit of RNA polymerase, which is a key enzyme involved in the synthesis of RNA from DNA. This process, known as transcription, is a crucial step in the expression of genes and the production of proteins.
The beta subunit of RNA polymerase, along with the beta' subunit, forms the core of the enzyme. These two subunits are responsible for the catalytic activity of the enzyme, which involves the addition of ribonucleotides to the growing RNA chain.
Role in Antibiotic Resistance[edit]
The RpoB gene is the target of the antibiotic rifampicin. This drug binds to the beta subunit of RNA polymerase and inhibits its activity, thereby preventing the synthesis of RNA and the expression of genes.
However, bacteria can develop resistance to rifampicin through mutations in the RpoB gene. These mutations alter the structure of the beta subunit, reducing the ability of rifampicin to bind to it and inhibit its activity.
Clinical Significance[edit]
Rifampicin resistance is a major problem in the treatment of tuberculosis, a disease caused by the bacterium Mycobacterium tuberculosis. The detection of RpoB mutations can be used as a marker for rifampicin resistance and can help guide the choice of treatment for tuberculosis patients.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
